Cargando…

The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses

BACKGROUND: The COVID-19 pandemic has disrupted cancer care, raising concerns regarding the impact of wait time, or ‘lag time’, on clinical outcomes. We aimed to contextualize pandemic-related lag times by mapping pre-pandemic evidence from systematic reviews and/or meta-analyses on the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Tope, Parker, Farah, Eliya, Ali, Rami, El-Zein, Mariam, Miller, Wilson H, Franco, Eduardo L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928418/
https://www.ncbi.nlm.nih.gov/pubmed/36718985
http://dx.doi.org/10.7554/eLife.81354
_version_ 1784888647979368448
author Tope, Parker
Farah, Eliya
Ali, Rami
El-Zein, Mariam
Miller, Wilson H
Franco, Eduardo L
author_facet Tope, Parker
Farah, Eliya
Ali, Rami
El-Zein, Mariam
Miller, Wilson H
Franco, Eduardo L
author_sort Tope, Parker
collection PubMed
description BACKGROUND: The COVID-19 pandemic has disrupted cancer care, raising concerns regarding the impact of wait time, or ‘lag time’, on clinical outcomes. We aimed to contextualize pandemic-related lag times by mapping pre-pandemic evidence from systematic reviews and/or meta-analyses on the association between lag time to cancer diagnosis and treatment with mortality- and morbidity-related outcomes. METHODS: We systematically searched MEDLINE, EMBASE, Web of Science, and Cochrane Library of Systematic Reviews for reviews published prior to the pandemic (1 January 2010–31 December 2019). We extracted data on methodological characteristics, lag time interval start and endpoints, qualitative findings from systematic reviews, and pooled risk estimates of mortality- (i.e., overall survival) and morbidity- (i.e., local regional control) related outcomes from meta-analyses. We categorized lag times according to milestones across the cancer care continuum and summarized outcomes by cancer site and lag time interval. RESULTS: We identified 9032 records through database searches, of which 29 were eligible. We classified 33 unique types of lag time intervals across 10 cancer sites, of which breast, colorectal, head and neck, and ovarian cancers were investigated most. Two systematic reviews investigating lag time to diagnosis reported different findings regarding survival outcomes among paediatric patients with Ewing’s sarcomas or central nervous system tumours. Comparable risk estimates of mortality were found for lag time intervals from surgery to adjuvant chemotherapy for breast, colorectal, and ovarian cancers. Risk estimates of pathologic complete response indicated an optimal time window of 7–8 weeks for neoadjuvant chemotherapy completion prior to surgery for rectal cancers. In comparing methods across meta-analyses on the same cancer sites, lag times, and outcomes, we identified critical variations in lag time research design. CONCLUSIONS: Our review highlighted measured associations between lag time and cancer-related outcomes and identified the need for a standardized methodological approach in areas such as lag time definitions and accounting for the waiting-time paradox. Prioritization of lag time research is integral for revised cancer care guidelines under pandemic contingency and assessing the pandemic’s long-term effect on patients with cancer. FUNDING: The present work was supported by the Canadian Institutes of Health Research (CIHR-COVID-19 Rapid Research Funding opportunity, VR5-172666 grant to Eduardo L. Franco). Parker Tope, Eliya Farah, and Rami Ali each received an MSc. stipend from the Gerald Bronfman Department of Oncology, McGill University.
format Online
Article
Text
id pubmed-9928418
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-99284182023-02-15 The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses Tope, Parker Farah, Eliya Ali, Rami El-Zein, Mariam Miller, Wilson H Franco, Eduardo L eLife Epidemiology and Global Health BACKGROUND: The COVID-19 pandemic has disrupted cancer care, raising concerns regarding the impact of wait time, or ‘lag time’, on clinical outcomes. We aimed to contextualize pandemic-related lag times by mapping pre-pandemic evidence from systematic reviews and/or meta-analyses on the association between lag time to cancer diagnosis and treatment with mortality- and morbidity-related outcomes. METHODS: We systematically searched MEDLINE, EMBASE, Web of Science, and Cochrane Library of Systematic Reviews for reviews published prior to the pandemic (1 January 2010–31 December 2019). We extracted data on methodological characteristics, lag time interval start and endpoints, qualitative findings from systematic reviews, and pooled risk estimates of mortality- (i.e., overall survival) and morbidity- (i.e., local regional control) related outcomes from meta-analyses. We categorized lag times according to milestones across the cancer care continuum and summarized outcomes by cancer site and lag time interval. RESULTS: We identified 9032 records through database searches, of which 29 were eligible. We classified 33 unique types of lag time intervals across 10 cancer sites, of which breast, colorectal, head and neck, and ovarian cancers were investigated most. Two systematic reviews investigating lag time to diagnosis reported different findings regarding survival outcomes among paediatric patients with Ewing’s sarcomas or central nervous system tumours. Comparable risk estimates of mortality were found for lag time intervals from surgery to adjuvant chemotherapy for breast, colorectal, and ovarian cancers. Risk estimates of pathologic complete response indicated an optimal time window of 7–8 weeks for neoadjuvant chemotherapy completion prior to surgery for rectal cancers. In comparing methods across meta-analyses on the same cancer sites, lag times, and outcomes, we identified critical variations in lag time research design. CONCLUSIONS: Our review highlighted measured associations between lag time and cancer-related outcomes and identified the need for a standardized methodological approach in areas such as lag time definitions and accounting for the waiting-time paradox. Prioritization of lag time research is integral for revised cancer care guidelines under pandemic contingency and assessing the pandemic’s long-term effect on patients with cancer. FUNDING: The present work was supported by the Canadian Institutes of Health Research (CIHR-COVID-19 Rapid Research Funding opportunity, VR5-172666 grant to Eduardo L. Franco). Parker Tope, Eliya Farah, and Rami Ali each received an MSc. stipend from the Gerald Bronfman Department of Oncology, McGill University. eLife Sciences Publications, Ltd 2023-01-31 /pmc/articles/PMC9928418/ /pubmed/36718985 http://dx.doi.org/10.7554/eLife.81354 Text en © 2023, Tope et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Epidemiology and Global Health
Tope, Parker
Farah, Eliya
Ali, Rami
El-Zein, Mariam
Miller, Wilson H
Franco, Eduardo L
The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses
title The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses
title_full The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses
title_fullStr The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses
title_full_unstemmed The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses
title_short The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses
title_sort impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the covid-19 pandemic: a scoping review of systematic reviews and meta-analyses
topic Epidemiology and Global Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928418/
https://www.ncbi.nlm.nih.gov/pubmed/36718985
http://dx.doi.org/10.7554/eLife.81354
work_keys_str_mv AT topeparker theimpactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT faraheliya theimpactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT alirami theimpactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT elzeinmariam theimpactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT millerwilsonh theimpactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT francoeduardol theimpactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT topeparker impactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT faraheliya impactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT alirami impactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT elzeinmariam impactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT millerwilsonh impactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses
AT francoeduardol impactoflagtimetocancerdiagnosisandtreatmentonclinicaloutcomespriortothecovid19pandemicascopingreviewofsystematicreviewsandmetaanalyses